ACHIEVE LIFE SCIENCES, INC. (ACHV)
$8.26+$0.08 (+0.98%) Today
Cindy Jacobs - OfficerAchieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
https://www.achievelifesciences.comSEC filings for ACHV on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 20,626 | $175K |
| Grant or award | 16 | 386,400 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
31 Form 4 filings on record, the earliest from Dec 9, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Richard Alistair Stewart - Director | Open-market sale | Common Stock | 20,626 | $8.49 | $175K | |
| Thomas Sellig - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Thomas Sellig - Director | Grant or award | Restricted Stock Unit (RSU) | 16,700 | $0.00 | - | |
| Christopher Nathan Martin - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Christopher Nathan Martin - Director | Grant or award | Restricted Stock Unit (RSU) | 16,700 | $0.00 | - | |
| Aaron Royston - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Aaron Royston - Director | Grant or award | Restricted Stock Unit (RSU) | 16,700 | $0.00 | - | |
 Reid Alexander Waldman - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Reid Alexander Waldman - Director | Grant or award | Restricted Stock Unit (RSU) | 16,700 | $0.00 | - | |
| Richard Alistair Stewart - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Richard Alistair Stewart - Director | Grant or award | Restricted Stock Unit (RSU) | 16,700 | $0.00 | - | |
| Jeffrey S. Farrow - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Jeffrey S. Farrow - Director | Grant or award | Restricted Stock Unit (RSU) | 16,700 | $0.00 | - | |
| Nancy R. Phelan - Director | Grant or award | Stock Option (right to buy) | 25,000 | $0.00 | - | |
| Nancy R. Phelan - Director | Grant or award | Restricted Stock Unit (RSU) | 16,700 | $0.00 | - | |
| Reid Alexander Waldman | Grant or award | Stock Option (right to buy) | 47,250 | $0.00 | - | |
| Jeffrey S. Farrow | Grant or award | Stock Option (right to buy) | 47,250 | $0.00 | - | |
| Christopher Nathan Martin | Grant or award | Stock Option (right to buy) | 47,250 | $0.00 | - | |
 Andrew D. Goldberg - Officer | Grant or award | Restricted Stock Unit (RSU) | 1,800,965 | $0.00 | - | |
| Andrew D. Goldberg - Officer | Grant or award | Stock Option (right to buy) | 3,601,929 | $0.00 | - | |
| Andrew D. Goldberg - Officer | Grant or award | Performance Restricted Stock Unit (PRSU) | 11,706,270 | $0.00 | - | |
| Mark Lawrence Rubinstein - Officer | Grant or award | Stock Option (right to buy) | 180,000 | $0.00 | - | |
| Mark K. Oki - Officer | Grant or award | Stock Option (right to buy) | 180,000 | $0.00 | - | |
| Jaime Xinos - Officer | Grant or award | Stock Option (right to buy) | 180,000 | $0.00 | - | |
| Craig Donnelly - Officer | Grant or award | Stock Option (right to buy) | 180,000 | $0.00 | - | |
| Richard Alistair Stewart - Officer | Grant or award | Stock Option (right to buy) | 645,000 | $0.00 | - | |
| Jerry Wan - Officer | Grant or award | Stock Option (right to buy) | 70,300 | $0.00 | - | |
| Erik Atkisson - Officer | Grant or award | Stock Option (right to buy) | 250,000 | $0.00 | - | |
| Craig Donnelly - Officer | Grant or award | Stock Option (right to buy) | 50,000 | $0.00 | - | |
| Mark K. Oki - Officer | Option exercise | Common Stock | 168,000 | $0.00 | - | |
| Mark K. Oki - Officer | Open-market sale | Common Stock | 50,060 | $2.92 | $146K | |
| Mark K. Oki - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 168,000 | $0.00 | - | |
| Richard Alistair Stewart - Officer | Option exercise | Common Stock | 297,500 | $0.00 | - | |
| Richard Alistair Stewart - Officer | Open-market sale | Common Stock | 129,501 | $2.92 | $378K | |
| Richard Alistair Stewart - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 140,000 | $0.00 | - | |
| Richard Alistair Stewart - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 157,500 | $0.00 | - | |
| Thomas Braxton King | Option exercise | Common Stock | 455,000 | $0.00 | - | |
| Thomas Braxton King | Open-market sale | Common Stock | 139,858 | $2.77 | $387K | |
| Thomas Braxton King | Option exercise | Performance Restricted Stock Unit (PRSU) | 455,000 | $0.00 | - | |
| Jerry Wan - Officer | Option exercise | Common Stock | 34,100 | $0.00 | - | |
| Jerry Wan - Officer | Open-market sale | Common Stock | 14,070 | $2.77 | $39K | |
| Jerry Wan - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 24,500 | $0.00 | - | |
| Jerry Wan - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 9,600 | $0.00 | - | |
| Jaime Xinos - Officer | Option exercise | Common Stock | 69,000 | $0.00 | - | |
| Jaime Xinos - Officer | Open-market sale | Common Stock | 20,854 | $2.77 | $58K | |
| Jaime Xinos - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 49,000 | $0.00 | - | |
| Jaime Xinos - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 20,000 | $0.00 | - | |
| Richard Alistair Stewart - Officer | Grant or award | Performance Restricted Stock Unit | 140,000 | $0.00 | - | |
| Richard Alistair Stewart - Officer | Grant or award | Performance Restricted Stock Unit | 157,500 | $0.00 | - | |
| Cindy Jacobs - Officer | Option exercise | Common Stock | 110,000 | $0.00 | - | |
| Cindy Jacobs - Officer | Open-market sale | Common Stock | 27,629 | $2.77 | $77K | |
| Cindy Jacobs - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 84,000 | $0.00 | - | |
| Cindy Jacobs - Officer | Option exercise | Performance Restricted Stock Unit (PRSU) | 26,000 | $0.00 | - | |
| Mark K. Oki - Officer | Grant or award | Performance Restricted Stock Unit | 168,000 | $0.00 | - | |
| Thomas Braxton King | Grant or award | Stock Option (right to buy) | 31,500 | $0.00 | - | |
| Jaime Xinos - Officer | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Stewart Richard Alistair | Director | 20,626 | $155K | View on EDGAR |
ACHIEVE LIFE SCIENCES, INC. (ACHV) had 10 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for ACHV runs to 31 Form 4 filings, the earliest from 2024-12-09. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ACHV were filed in the last 90 days.
1 insider sale of ACHV was filed in the last 90 days, totaling $175K.
This page tracks ACHV Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ACHV to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
